Independent research tool — not a government agency. Official notices govern.Refreshed
OpenResearch announcementOpportunity HT942526VRPCTA

DoW Vision, Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Vision, Clinical Trial Award is an open federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due November 12, 2026. Total estimated funding is $2.6M across about 1 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. May 5, 2026Posted
  2. Nov 12, 2026Application deadlinenext date
  3. Sep 30, 2027 (est.)Est. award date
  4. Dec 12, 2026Archived
Posted
May 5, 2026
Close date
Nov 12, 2026
Archive date
Dec 12, 2026
Est. award date
Sep 30, 2027
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
$2,600,000
Implied average award
$2,600,000 calculated
Expected awards
1
Cost sharing
Not required
Funding instrument
Grant
Opportunity category
Discretionary

Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

  • Unrestricted (any entity type)

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas.  

Distinctive Features:

·       For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details.

·       Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication.

·       Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health.

https://cdmrp.health.mil/pubs/press/2026/vrppreann

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

How to apply

0 of 8 done · progress saved in this browser

Assistance Listing

What is an ALN?

Reported obligations under ALN 12.420

Historical data · not a prediction
FY24$1.48B
FY25$1.2B
FY26— est.
Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Teresa M Parker-Reeser Grants Officer
help@eBRAP.org
3016192171

Quick answers

When is the deadline for “DoW Vision, Clinical Trial Award”?

According to the official notice, applications are due November 12, 2026. Confirm the deadline and submission time on Grants.gov before applying.

Who is eligible to apply for “DoW Vision, Clinical Trial Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Vision, Clinical Trial Award”?

Per the notice, total estimated program funding is $2,600,000 and the agency expects to make about 1 awards.

How do I apply for “DoW Vision, Clinical Trial Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526VRPCTA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 12 daysResearchALN 12.420

DoW Military Burn, Patient-Centered Research Award

Defense Health Agency Contracting Activity - DHACA
Award range
Amount not specified
Closes
Oct 21, 2026
Who can apply
Unrestricted (any entity type)
Source: Grants.govVerified today
Closes in 13 daysResearchALN 12.420

DoW Autism Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA
Award range
Amount not specified
Closes
Oct 22, 2026
Who can apply
Unrestricted (any entity type)
Source: Grants.govVerified today
Closes in 13 daysResearchALN 12.420

DoW Arthritis Clinical Research Award

Defense Health Agency Contracting Activity - DHACA
Award range
Amount not specified
Closes
Oct 22, 2026
Who can apply
Unrestricted (any entity type)
Source: Grants.govVerified today